Michael Sandherr

2.0k total citations
35 papers, 1.2k citations indexed

About

Michael Sandherr is a scholar working on Oncology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Michael Sandherr has authored 35 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 14 papers in Epidemiology and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Michael Sandherr's work include Neutropenia and Cancer Infections (10 papers), Lymphoma Diagnosis and Treatment (10 papers) and Antifungal resistance and susceptibility (6 papers). Michael Sandherr is often cited by papers focused on Neutropenia and Cancer Infections (10 papers), Lymphoma Diagnosis and Treatment (10 papers) and Antifungal resistance and susceptibility (6 papers). Michael Sandherr collaborates with scholars based in Germany, United States and Switzerland. Michael Sandherr's co-authors include Georg Maschmeyer, Oliver A. Cornely, Olaf Penack, Marie von Lilienfeld‐Toal, Dieter Buchheidt, Andrew J. Ullmann, Meinolf Karthaus, Werner Heinz, Silke Neumann and Christian Peschel and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Lancet Oncology.

In The Last Decade

Michael Sandherr

34 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Sandherr Germany	21	544	492	413	250	185	35	1.2k
Hans‐Heinrich Wolf Germany	20	427 0.8×	480 1.0×	465 1.1×	115 0.5×	100 0.5×	42	1.3k
Montserrat Arnán Spain	19	469 0.9×	537 1.1×	418 1.0×	133 0.5×	123 0.7×	53	1.3k
Timothy P. Cooley United States	27	780 1.4×	482 1.0×	879 2.1×	408 1.6×	138 0.7×	52	2.0k
Alain Kentos Belgium	18	284 0.5×	288 0.6×	199 0.5×	127 0.5×	146 0.8×	58	1.4k
Claude‐Eric Bulabois France	18	331 0.6×	222 0.5×	175 0.4×	272 1.1×	117 0.6×	63	956
Xaver Schiel Germany	19	570 1.0×	542 1.1×	267 0.6×	76 0.3×	51 0.3×	36	1.2k
Anne Vekhoff France	21	600 1.1×	589 1.2×	591 1.4×	278 1.1×	239 1.3×	58	1.9k
Yukiko Kishi Japan	22	456 0.8×	280 0.6×	176 0.4×	195 0.8×	131 0.7×	61	1.2k
Erika Borlenghi Italy	19	462 0.8×	177 0.4×	159 0.4×	229 0.9×	216 1.2×	59	1.2k
Hamdi Akan Türkiye	26	555 1.0×	775 1.6×	602 1.5×	58 0.2×	125 0.7×	106	1.8k

Countries citing papers authored by Michael Sandherr

Since Specialization

Citations

This map shows the geographic impact of Michael Sandherr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Sandherr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Sandherr more than expected).

Fields of papers citing papers by Michael Sandherr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Sandherr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Sandherr. The network helps show where Michael Sandherr may publish in the future.

Co-authorship network of co-authors of Michael Sandherr

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Sandherr. A scholar is included among the top collaborators of Michael Sandherr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Sandherr. Michael Sandherr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Henze, Larissa, Michael Sandherr, Oliver A. Cornely, et al.. (2022). Management of herpesvirus reactivations in patients with solid tumours and hematologic malignancies: update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO) on herpes simplex virus type 1, herpes simplex virus type 2, and varicella zoster virus. Annals of Hematology. 101(3). 491–511. 36 indexed citations

Claßen, Annika Y., Larissa Henze, Marie von Lilienfeld‐Toal, et al.. (2021). Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO/DGHO). Annals of Hematology. 100(6). 1603–1620. 46 indexed citations

Giesen, Nicola, Rosanne Sprute, Maria Madeleine Rüthrich, et al.. (2021). 2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapy. European Journal of Cancer. 147. 154–160. 31 indexed citations

Heinz, Werner, Dieter Buchheidt, Maximilian Christopeit, et al.. (2017). Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Annals of Hematology. 96(11). 1775–1792. 100 indexed citations

Sandherr, Michael, Marcus Hentrich, Marie von Lilienfeld‐Toal, et al.. (2015). Antiviral prophylaxis in patients with solid tumours and haematological malignancies—update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO). Annals of Hematology. 94(9). 1441–1450. 66 indexed citations

Rummel, Mathias, Ulrich Kaiser, Christina Balser, et al.. (2015). Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trial. The Lancet Oncology. 17(1). 57–66. 110 indexed citations

Tacke, Daniela, Dieter Buchheidt, Meinolf Karthaus, et al.. (2014). Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology. Annals of Hematology. 93(9). 1449–1456. 59 indexed citations

Straka, Christian, Hans Salwender, Michael Sandherr, et al.. (2014). Granulocyte-colony stimulating factor response is superior to neutropenia duration in predicting the risk of infection after high-dose chemotherapy for myeloma and lymphoma. Leukemia & lymphoma. 56(2). 368–376.

Weißinger, Florian, Holger W. Auner, Hartmut Bertz, et al.. (2012). Antimicrobial therapy of febrile complications after high-dose chemotherapy and autologous hematopoietic stem cell transplantation—guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Annals of Hematology. 91(8). 1161–1174. 28 indexed citations

10.

Maschmeyer, Georg & Michael Sandherr. (2009). Infektionen in der Hämatologie und Onkologie. Der Internist. 50(2). 187–202. 1 indexed citations

11.

Cornely, Oliver A., Angelika Böhme, Dieter Buchheidt, et al.. (2008). Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology. Haematologica. 94(1). 113–122. 137 indexed citations

12.

Schuler, Ulrich S., Walter E. Aulitzky, Claudia R. Binder, et al.. (2007). Safety and Efficacy of Itraconazole Compared to Amphotericin B as Empirical Antifungal Therapy for Neutropenic Fever in Patients with Haematological Malignancy*. Oncology Research and Treatment. 30(4). 185–191. 24 indexed citations

13.

Sandherr, Michael, Hermann Einsele, Holger Hebart, et al.. (2006). Antiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO). Annals of Oncology. 17(7). 1051–1059. 72 indexed citations

14.

Frickhofen, Norbert, Wolfgang E. Berdel, Rainer Haas, et al.. (2006). Phase I/II trial of multicycle high-dose chemotherapy with peripheral blood stem cell support for treatment of advanced ovarian cancer. Bone Marrow Transplantation. 38(7). 493–499. 10 indexed citations

15.

Bogner, Christian, et al.. (2006). Cyclin E but not bcl-2, bax or mcl-1 is differentially expressed in ZAP 70-positive and ZAP 70-negative B-CLL cells. Annals of Hematology. 85(7). 458–462. 9 indexed citations

16.

Cornely, Oliver A., Michael Sandherr, Thomas Kubin, et al.. (2005). Empirical antimicrobial monotherapy in patients after high‐dose chemotherapy and autologous stem cell transplantation: a randomised, multicentre trial. British Journal of Haematology. 130(2). 265–270. 25 indexed citations

17.

Bertz, Hartmut, Holger W. Auner, Florian Weißinger, et al.. (2003). Antimicrobial therapy of febrile complications after high-dose chemo-/radiotherapy and autologous hematopoietic stem cell transplantation. Annals of Hematology. 82(0). S167–S174. 22 indexed citations

18.

Kremer, Marcus, et al.. (2001). Epstein-Barr Virus–Negative Hodgkin's Lymphoma After Mycosis Fungoides: Molecular Evidence for Distinct Clonal Origin. Modern Pathology. 14(2). 91–97. 13 indexed citations

19.

Weirich, Gregor, Michael Sandherr, Christian Fellbaum, et al.. (1998). Molecular evidence of bone marrow involvement in advanced case of Tγδ lymphoma with secondary myelofibrosis. Human Pathology. 29(7). 761–765. 13 indexed citations

20.

Kotzerke, J., et al.. (1996). Vortäuschung eines mediastinalen Non-Hodgkin-Lymphomrezidivs durch diffuse Thymushyperplasie im¹⁸F-FDG-PET. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 165(9). 309–310. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact